Diagnostic yield of flexible bronchoscopy for immunocompromised patients with lung infiltrates: A single-center,

Natsuki Nakagawa1, Takahiro Ando1, Masanori Kawakami1

  • 1Department of Respiratory Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

PubMed

Insights

Bronchoscopy aids diagnosis in immunocompromised patients with lung issues. Transbronchial biopsy improves diagnostic yield, proving useful for various underlying conditions, including collagen vascular disease.

Area of Science:

  • Pulmonology
  • Immunology
  • Medical Diagnostics

Background:

  • Pulmonary complications significantly increase mortality in immunocompromised patients.
  • Bronchoscopy is a recognized tool, but factors influencing its diagnostic yield remain unclear.
  • Identifying these factors is crucial for optimizing patient care.

Purpose of the Study:

  • To evaluate clinical factors and procedures impacting bronchoscopy's diagnostic yield in immunocompromised patients.
  • To assess the safety and efficacy of bronchoscopy in this vulnerable population.
  • To determine the utility of bronchoscopy for diagnosing diverse pulmonary conditions.

Main Methods:

  • Retrospective analysis of 115 bronchoscopies in 108 immunocompromised patients (corticosteroid/immunosuppressant users).
  • Evaluation of clinical data, sampling techniques, diagnoses, and complications.
  • Statistical analysis to identify factors influencing diagnostic yield.

Main Results:

  • Bronchoscopy yielded a clinical diagnosis in 44% of patients (infectious and non-infectious diseases).
  • Transbronchial biopsy significantly improved diagnostic yield (54.7% vs. 35.5%, P=0.049).
  • Bronchoscopy proved useful for collagen vascular disease and other disorders; severe complications were rare (0.9%).

Conclusions:

  • Transbronchial biopsy is a valuable procedure for diagnosing pulmonary infiltrates in immunocompromised individuals.
  • Bronchoscopy is a useful diagnostic tool for immunocompromised patients, including those with collagen vascular disease.
  • The study supports the continued use of bronchoscopy for managing complex pulmonary cases in immunocompromised patients.
Abstract